Reimbursement for diagnostic testing related to the SARS-CoV-2 virus, utilizing funds from Flexible Spending Arrangements, is a common inquiry. These arrangements allow pre-tax dollars to be set aside for qualified healthcare expenses. A typical example would involve purchasing an at-home test and submitting the receipt for reimbursement from the FSA account.
The significance of this eligibility stems from the potential to reduce healthcare costs for individuals and families. Historically, the availability of FSA funds for these tests has fluctuated depending on government regulations and public health emergency declarations. The ability to use pre-tax dollars for such expenses effectively lowers the out-of-pocket cost, making testing more accessible.
